2021 Virtual Workshop – Innovative Approaches to Drug Safety
Veracuity Blog 2021 Virtual Workshop – Innovative Approaches to Drug Safety Register Workshop information flyer
Will pharmacogenomic testing become a routine part of clinical care?
Veracuity Blog Will pharmacogenomic testing become a routine part of clinical care? Some adverse drug events are a predictable consequence of therapeutic, especially dosing failures. Idiosyncratic toxicities, on the other hand, are much less predictable and much more insidious. Pharmacogenomics is a powerful tool that can reveal some of these vulnerabilities before toxicity occurs or,…
Utilizing pharmacogenomic testing to ensure effective therapy
Veracuity Blog Will pharmacogenomic testing become a routine part of clinical care? Some medications are administered as prodrugs that need to be metabolized in the active form by the body. An example of such a drug is codeine. It undergoes biotransformation into morphine by CYP2D6. Patients who transform codeine faster who are referred to as…
Adverse incidents of medical devices
Veracuity Blog Adverse incidents of medical devices Medical Devices Regulation 2017/745 and In Vitro Diagnostic Medical Devices Regulation 2017/746 The new European legislation places numerous new obligations on manufacturers of medical devices marketed in Europe. The current requirements for reporting adverse incidents of medical devices in Europe are detailed in the Medical Devices Directive (MDD)…